Immunology articles for Germany

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 195

Article ‘Count’ for Immunology.

Journal Count Share
1 1.00
Flow-Induced Vascular Remodeling on-Chip: Implications for Anti-VEGF Therapy 1.00
1 0.06
Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study 0.06
3 1.26
Fluorine-18-Labeled Nucleotide Analogs Targeting Ecto-5'-Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors 0.71
Decoding a Gut Commensal Signal: Structural and Immunological Profiling of Segatella Copri Lipopolysaccharide 0.06
Glycosylation‐Dependent Stability of Human Pentraxin‐2 Revealed by Surface‐Induced Dissociation and Ion Mobility Mass Spectrometry 0.50
2 0.24
A pathogenic gut lipoglycan drives systemic thromboinflammation in lupus nephritis 0.06
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndrome 0.18
3 1.28
The potential role of synovial T‐cell infiltration following knee joint injury in symptoms and progression to osteoarthritis 0.21
Interleukin‐2 deprived state of regulatory T cells and their recovery by low‐dose interleukin‐2 in patients with inflammatory myopathies 1.00
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING‐Associated Vasculopathy with Onset in Infancy Refractory to scpJAK/scp Inhibitor and Dazukibart Therapy 0.07
8 4.29
Gastrin for the treatment of acute graft-versus-host disease of the stomach 1.00
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis 0.04
Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis 0.20
RhoA GAP Myo9b regulates β2-integrin activity and neutrophil recruitment during murine acute kidney injury. 0.93
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study 0.03
HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study 0.10
Augmented CD47 expression impairs alloreactive T cell clearance after allo-HCT 1.00
Expansions of circulating plasmablasts producing commensal-reactive IgA antibodies are predictors for chronic GVHD 1.00
2 1.04
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis 0.04
Role of CD5 signalling for pro-inflammatory Th17 response in multiple sclerosis 1.00
1 0.05
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche 0.05
3 0.61
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 Inactivation. 0.11
Systemic Inactivation of TREX1 Induces Selective Inflammation of the Tumor Microenvironment and Invigorated T-cell–Mediated Tumor Control 0.39
Ammonia Suppresses the Antitumor Activity of Natural Killer Cells and T Cells by Decreasing Mature Perforin 0.11
1 0.25
Centromeric DNA amplification triggered by viral proteins activates nuclear cGAS 0.25
1 0.15
Age-related impairment of intestinal inflammation resolution through an eicosanoid-immune-microbiota axis 0.15
2 1.11
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old 0.11
Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection 1.00
1 0.09
Myosin II regulates cellular thermo-adaptability and the efficiency of immune responses 0.09
2 1.50
Effect of High-Dose Oral Insulin in Children With Stage 1 Type 1 Diabetes: The Fr1da Insulin Intervention Randomized Controlled Trial. 1.00
Generalizability of Progression Risk in the TN-10 Trial to a European Population With or Without a First-Degree Relative With Type 1 Diabetes. 0.50
1 0.56
Neutrophil extracellular traps and peptidylarginine deiminase 4–mediated inflammasome activation link diabetes to cardiorenal injury and heart failure 0.56
1 1.00
CD16+ γδ T cells mediate antibody-dependent cellular cytotoxicity and associate with viral control in chronic hepatitis B virus infection 1.00
10 6.02
Acute and chronic infections drive distinct trajectories in human memory CD4+ T cell formation 0.94
Microglia-glioblastoma crosstalk mediates glioblastoma invasion at the far infiltration zone 0.93
Perinatal infection elicits clonally restricted T follicular helper cell responses that drive antibody-mediated viral control 0.04
Antibody-mediated feedback modulates interclonal competition in the germinal center 0.04
Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes 0.14
Tolerance to ferroptosis facilitates lipid metabolism and pathogenic type 2 immunity in allergic airway inflammation 1.00
Clonal persistence dominates homeostatic intestinal IgA responses 0.89
Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures 1.00
A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer 1.00
Diet-derived LPS determines intestinal IgA induction and repertoire characteristics independently of the microbiota 0.03
1 1.00
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections 1.00
1 0.01
Precision Immunotherapy to Improve Sepsis Outcomes 0.01
4 1.79
Elongator is required for pattern recognition receptor and type I interferon signaling in macrophages. 0.43
Surface emergence and persistence of MHC class I free heavy chains 0.60
Annexin A2 interferes with complement regulation within the glomerulus 0.07
Inflammasome-independent IL-1β activation via staphopain A protease of Staphylococcus aureus 0.69
1 0.06
uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells 0.06
5 4.11
Characterization of intestinal immune responses in generalized human and murine lipodystrophy 1.00
Type I IFN–dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections 0.95
Selective disruption of RORγt-CBFβ interaction by IMU-935 prevents RORγt-dependent Th17 autoimmunity but not thymocyte development 0.26
TNF Superfamily Member 14 Drives Post-Influenza Depletion of Alveolar Macrophages Enabling Secondary Pneumococcal Pneumonia 0.89
Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis 1.00
7 1.68
Hypoxia-inducible protein 2 mediates metabolic adaptation of Ly6ChighLy6Glow monocytes after stroke 0.11
Genetically heterozygous - transcriptionally homozygous IRF7 deficiency underlies herpesvirus CNS infections in humans 0.01
Dominant negative iADA2/i mutations cause ADA2 deficiency in heterozygous carriers 0.04
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action 0.26
Epitope and HLA specificity of human TCRs against iPlasmodium falciparum/i circumsporozoite protein 0.67
Factor XII–driven coagulation traps bacterial infections 0.51
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy 0.08
2 1.71
Molecular signatures discriminating different types of rejection in human liver transplants 0.74
Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD 0.96
3 1.90
Lack of S100A8 Impairs Lung-Protective Immunity Against Streptococcus pneumoniae 0.93
Sex Differences in Vaccine-Induced Immunity and Protection Against Mycobacterium tuberculosis 0.92
A Functional Polymorphism in IL-36β Modulates Macrophage Antifungal Effector Functions and Increases Susceptibility to Invasive Pulmonary Aspergillosis 0.05
1 0.09
CLUH Inhibition by Lipocalin-2 Orchestrates Mitochondrial Disruption and Contributes to Kidney Disease 0.09
4 0.20
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy 0.06
Macrophages mediate acute kidney allograft rejection via a toll-like receptor 4-dependent mechanism 0.06
Multi-omic factor analyses uncovered cross-compartment complexity of biological processes in kidney transplantation 0.08
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranous proliferative glomerulonephritis using the United Kingdom RaDaR Registry 0.00
2 1.09
Regulation of somatic hypermutation by higher-order chromatin structure 0.09
Structural basis for OAS2 regulation and its antiviral function 1.00
2 1.04
Nanoscale Mapping Reveals Periodic Organization of Neutrophil Extracellular Trap Proteins 1.00
Tiny Clusters for Big Impact in T Cell Activation 0.04
8 2.77
Targeting excessive cholesterol deposition alleviates secondary lymphoedema 0.04
The transition from monocyte to tissue-resident macrophage requires DHPS 0.22
Erythropoietin receptor on cDC1s dictates immune tolerance 0.03
Architecture of the neutrophil compartment 0.08
Ribonucleotide incorporation into mitochondrial DNA drives inflammation 0.64
Myeloperoxidase transforms chromatin into neutrophil extracellular traps 1.00
STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD 0.70
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells 0.06
2 0.66
Lysine-11 ubiquitination drives type-I/III interferon induction by cGAS–STING and Toll-like receptors 3 and 4 0.50
Autophagy-regulated mitochondrial inheritance controls early CD8+ T cell fate commitment 0.16
38 18.95
Complement inhibition by a unique cluster of immunomodulatory outer surface proteins of Borrelia recurrentis 1.00
Type I interferon drives T cell responses to amyloid beta in the central nervous system 1.00
Maternal antibodies regulate the establishment of murine oral and salivary mucosal immunity 0.03
Versatile and sensitive detection of mono- and poly(ADP-ribosyl)ation reveals XRCC1-dependent remodelling of PARP1 signalling 1.00
Molecular signatures and causal factors underlying latent cytomegalovirus infection among people living with HIV (PLHIV) 0.35
Nanobody-based IgG simultaneously inhibit the allergenic and enzymatic activity of the dominant honeybee venom allergen 0.29
Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn’s disease 1.00
Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer 0.10
Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection 0.91
Evolution of the tuberculin skin test reveals generalisable Mtb-reactive T cell metaclones 0.02
A centrally positioned cluster of multiple centrioles in antigen-presenting cells fosters T cell activation 0.78
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 0.05
Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1 0.20
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer 1.00
Discovery of an allosteric binding site for anthraquinones at the human P2X4 receptor 0.97
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.01
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection 0.03
Preclinical assessment of two FcγRI-specific antibodies that competitively inhibit immune complex-FcγRI binding to suppress autoimmune responses 0.14
Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis 0.98
Hypoxic-ischemic brain injury in neonatal mice sequentially recruits neutrophils with dichotomous phenotype and function 0.91
Tissue localization of natural killer cells dictates surveillance of lung metastasis 0.17
Artificial Intelligence (AI)-assisted readout method for the evaluation of skin prick automated test results 0.09
Neuron-reactive KIR+CD8+ T cells display an encephalitogenic transcriptional program in autoimmune encephalitis 0.08
A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptor 0.31
Progressive changes in phenotype, transcriptome and proliferation capacity characterise continued maturation and migration of intestinal cDCs in homeostasis 0.87
CD4+T-cells create a stable mechanical environment for force-sensitive TCR:pMHC interactions 0.25
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target 0.69
B cell maturation antigen (BCMA) is dispensable for the survival of long-lived plasma cells 1.00
TLR4group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases 0.08
Variable lymphocyte receptor F is generated via somatic diversification and expressed by lamprey T-like cells 0.20
Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts 0.12
Developmental features and unique characteristics of peptide-specific PLZF innate-like T cells in mice 1.00
Polyketide synthase-derived sphingolipids mediate microbiota protection against a bacterial pathogen in C. elegans 0.83
Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD 1.00
Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly 0.14
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice 1.00
TRIM23 mediates cGAS-induced autophagy in anti-HSV defense 0.21
Structural insight into TLR4/MD-2 activation by synthetic LPS mimetics with distinct binding modes 0.14
20 4.15
Tissue-restricted secondary TCR engagement drives the transition from stem-like to CD200 Egr2 arthritogenic Th17 cells 0.08
HLA class I signal peptide variation predicts strength of NKG2A NK cell response to missing-self and risk of human disease 0.08
CD38 endows local antigen-specific Treg cells with stress resilience for control of compartmentalized CNS inflammation 0.86
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function 0.04
A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID 0.87
Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy 0.13
Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury 0.04
Adenophages are an atypical macrophage population in exocrine glands sustained by ILC2-derived GM-CSF 0.06
Tissue-resident exhausted and memory CD8 T cells have distinct ontogeny, function and roles in disease 0.01
DC subsets and states unraveled across human juxtatumoral and malignant tissues 0.03
Neuroepithelial VIP–VIPR1 interactions differentially control enteric type 1 and type 2 immunity 0.16
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer 0.26
The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells 0.03
Transient tissue residency and lymphatic egress define human CD56 NK cell homeostasis 0.09
Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells 0.02
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade 0.16
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity 0.03
DNA hypomethylation traits define human regulatory T cells in cutaneous tissue and identify their blood recirculating counterparts 1.00
Migrating immune cells globally coordinate protrusive forces 0.04
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 0.16
1 0.06
Interpretable inflammation landscape of circulating immune cells 0.06
1 0.05
Neurodevelopmental origins of structural and psychomotor defects in CXCR4-linked primary immunodeficiency 0.05
1 0.07
Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response 0.07
13 3.81
Proton-activated chloride channel 1 is essential for innate host defense against bacterial sepsis 0.32
Chronic infection perturbs the affinity hierarchy of antiviral B cells 0.04
CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination 0.01
Tim-3-targeted vaccines overcome tumor immunosuppression and reduce cDC1 dependence to elicit potent anti-tumor immunity 0.20
Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2 0.01
Immune cells employ intermittent integrin-mediated traction forces for 3D migration 0.99
Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19 0.05
Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility 0.03
Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer 0.05
Synovial MS4A4A correlates with inflammation and counteracts response to corticosteroids in arthritis 0.05
AhR signaling in skin-resident CD207+ cells is involved in UV-B-induced amelioration of neuroinflammation 1.00
Arylsulfamates inhibit colonic Bacteroidota growth through a sulfatase-independent mechanism 0.07
SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive binding 1.00
2 0.83
Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation 0.78
Type 2 cytokines act on enteric sensory neurons to regulate neuropeptide-driven host defense 0.06
12 4.37
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoire 0.66
Pathogenic GM-CSF drives functional diversification of inflammatory macrophages in autoimmune arthritis 0.14
Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome 0.08
Architectural principles of transporter-chaperone coupling within the native MHC I peptide-loading complex 0.88
HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumors 0.14
Single-cell multiome and spatial profiling reveals pancreas cell type–specific gene regulatory programs of type 1 diabetes progression 0.12
IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas 0.07
STAT3 haploinsufficiency is associated with autosomal dominant hyper-IgE syndrome 0.92
A human NK cell progenitor that originates in the thymus and generates KIR+NKG2A− NK cells 1.00
PD-1 and ICOS are coexpressed in T follicular helper cells but define three stages of maturation of T follicular regulatory cells 0.05
Celluloepidemiology—A paradigm for quantifying infectious disease dynamics on a population level 0.03
Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction 0.29
2 0.86
A vaccine targeting human IgE induces long-term protection against anaphylaxis in humanized mice 0.06
Bruton’s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell–mediated lymphotoxin-α release 0.80
6 4.36
T-cell protrusions enable fast, localised initiation of chimeric antigen receptor signalling 0.81
CD20 tails interact with the 14-3-3/GEF-H1 complex and microtubule network upon PKCδ phosphorylation 0.95
Poxvirus dsDNA genomes differentially activate AIM2 or NLRP3 inflammasomes in human primary cells 0.88
Proteolytic profiling of human plasma reveals an immunoactive complement C3 fragment. 0.41
Basal IFN-λ2/3 expression mediates tight junction formation in human epithelial cells 0.31
PARP7 is a proteotoxic stress sensor that labels proteins for degradation 1.00
7 2.83
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial 0.05
Soluble FcεRI is increased in advanced mastocytosis and acts as a negative regulator of mast cell expansion and activation 0.06
Epidemiology and Management of Malignancies in Patients with Inborn Errors of Immunity - An ESID Registry Study of 19,959 Patients 0.45
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation 0.12
Late Effects After Haematopoietic Stem Cell Transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP and TCWP EBMT Study 0.17
Mast cells modulate macrophage biology through release of pre-stored CSF1 0.98
Ingestion of mast cell granules boosts macrophages and drives atypical programming 1.00
2 0.69
Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial 0.54
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial 0.15
3 0.14
Iptacopan in IgA Nephropathy — Final 24-Month Data 0.03
Ianalumab plus Eltrombopag in Immune Thrombocytopenia 0.08
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.03
1 0.01
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.01

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.